Trial record 1 of 8 for:    Leber congenital amaurosis phase 3
Previous Study | Return to List | Next Study

Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Children's Hospital of Philadelphia
University of Iowa
Information provided by (Responsible Party):
Spark Therapeutics
ClinicalTrials.gov Identifier:
NCT00999609
First received: October 21, 2009
Last updated: July 22, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2029
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: February 16, 2016